Inventor · disambiguated record
David A. Nelles
Also filed as: NELLES DAVID · NELLES DAVID A · NELLES DAVID ALLEN
5 granted patents·17 pending applications·6 citations·filing 2016–2024
71Inventor score
Top patents by PatentIndex Score
22 records- 0187US11667903B2Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9UNIV CALIFORNIA·Filed 2020·Granted Jun 6, 2023·3 cites·20 claims
- 0277US11453891B2Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9UNIV CALIFORNIA·Filed 2018·Granted Sep 27, 2022·2 cites·20 claims
- 0377US10822617B2RNA-targeting fusion protein compositions and methods for useLOCANA INC·Filed 2019·Granted Nov 3, 2020·1 cites·11 claims
- 0475US2023365951A1Tracking and Manipulating Cellular RNA via Nuclear Delivery of CRISPR/CAS9UNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0568US2024344060A1Compositions and methods for the modulation of adaptive immunityLOCANABIO INC·Filed 2023·Application pending·0 cites
- 0668US2025051764A1Rna editing via recruitment of spliceosome componentsTACIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0767US12163148B2Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9UNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·11 claims
- 0867US12152239B2RNA editing via recruitment of spliceosome componentsTACIT THERAPEUTICS INC·Filed 2023·Granted Nov 26, 2024·0 cites·13 claims
- 0961US2021047654A1Rna-targeting fusion protein compositions and methods for useLOCANA INC·Filed 2020·Application pending·0 cites
- 1061US2023127548A1Methods for identifying a cell uptake mechanismUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1158US2020071718A1Rna-targeting fusion protein compositions and methods for useLOCANA INC·Filed 2019·Application pending·0 cites
- 1258US2024209366A1High efficiency trans-splicing for replacement of targeted rna sequences in human cellsTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1356US2025290067A1Localization of trans-splicing nucleic acid molecules to and within the cellular nucleusTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1456US2023340469A1Trans-splicing system for tissue-specific replacement of rna sequencesTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1553US2025270553A1Stabilization of therapeutic trans-splicing rna molecules in human cellsTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1652US2019382759A1Compositions and methods for the modulation of adaptive immunityLOCANA INC·Filed 2019·Application pending·0 cites
- 1751US2019040370A1Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9UNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1848US2024108751A1Rna-targeting compositions and methods for treating myotonic dystrophy type 1LOCANABIO INC·Filed 2021·Application pending·0 cites
- 1948US2021009987A1Rna-targeting knockdown and replacement compositions and methods for useLOCANA INC·Filed 2020·Application pending·0 cites
- 2048US2024000972A1Rna-targeting compositions and methods for treating cag repeat diseasesLOCANABIO INC·Filed 2021·Application pending·0 cites
- 2146US2017145394A1Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9UNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 2245US2022175960A1Fasl immunomodulatory gene therapy compositions and methods for useLOCANABIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Nelles files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →